Unknown

Dataset Information

0

Endolysin LysEF-P10 shows potential as an alternative treatment strategy for multidrug-resistant Enterococcus faecalis infections.


ABSTRACT: Phage-derived lysins can hydrolyse bacterial cell walls and show great potential for combating Gram-positive pathogens. In this study, the potential of LysEF-P10, a new lysin derived from a isolated Enterococcus faecalis phage EF-P10, as an alternative treatment for multidrug-resistant E. faecalis infections, was studied. LysEF-P10 shares only 61% amino acid identity with its closest homologues. Four proteins were expressed: LysEF-P10, the cysteine, histidine-dependent amidohydrolase/peptidase (CHAP) domain (LysEF-P10C), the putative binding domain (LysEF-P10B), and a fusion recombination protein (LysEF-P10B-green fluorescent protein). Only LysEF-P10 showed highly efficient, broad-spectrum bactericidal activity against E. faecalis. Several key functional residues, including the Cys-His-Asn triplet and the calcium-binding site, were confirmed using 3D structure prediction, BLAST and mutation analys. We also found that calcium can switch LysEF-P10 between its active and inactive states and that LysEF-P10B is responsible for binding E. faecalis cells. A single administration of LysEF-P10 (5??g) was sufficient to protect mice against lethal vancomycin-resistant Enterococcus faecalis (VREF) infection, and LysEF-P10-specific antibody did not affect its bactericidal activity or treatment effect. Moreover, LysEF-P10 reduced the number of Enterococcus colonies and alleviated the gut microbiota imbalance caused by VREF. These results indicate that LysEF-P10 might be an alternative treatment for multidrug-resistant E. faecalis infections.

SUBMITTER: Cheng M 

PROVIDER: S-EPMC5579260 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Endolysin LysEF-P10 shows potential as an alternative treatment strategy for multidrug-resistant Enterococcus faecalis infections.

Cheng Mengjun M   Zhang Yufeng Y   Li Xinwei X   Liang Jiaming J   Hu Liyuan L   Gong Pengjuan P   Zhang Lei L   Cai Ruopeng R   Zhang Hao H   Ge Jinli J   Ji Yalu Y   Guo Zhimin Z   Feng Xin X   Sun Changjiang C   Yang Yongjun Y   Lei Liancheng L   Han Wenyu W   Gu Jingmin J  

Scientific reports 20170831 1


Phage-derived lysins can hydrolyse bacterial cell walls and show great potential for combating Gram-positive pathogens. In this study, the potential of LysEF-P10, a new lysin derived from a isolated Enterococcus faecalis phage EF-P10, as an alternative treatment for multidrug-resistant E. faecalis infections, was studied. LysEF-P10 shares only 61% amino acid identity with its closest homologues. Four proteins were expressed: LysEF-P10, the cysteine, histidine-dependent amidohydrolase/peptidase (  ...[more]

Similar Datasets

| S-EPMC10078070 | biostudies-literature
| S-EPMC4466700 | biostudies-other
| S-EPMC3827423 | biostudies-literature
| S-EPMC6084283 | biostudies-literature
| S-EPMC4402337 | biostudies-literature
| S-EPMC521886 | biostudies-literature
| S-EPMC7564645 | biostudies-literature
| S-EPMC296199 | biostudies-literature
| S-EPMC11225414 | biostudies-literature
| S-EPMC9228330 | biostudies-literature